Predictive impact of fibrinogen-to-albumin ratio (FAR) for left ventricular dysfunction in acute coronary syndrome: a cross-sectional study

Eur J Med Res. 2023 Feb 8;28(1):68. doi: 10.1186/s40001-023-01029-2.

Abstract

Background: The significantly prognostic value of fibrinogen-to-albumin ratio (FAR) has been proved in patients with coronary artery disease and different oncologic disorders. This study aimed to investigate the predictive value of FAR for left ventricular systolic dysfunction (LVSD) in acute coronary syndromes (ACS) patients.

Methods: A total of 650 ACS patients after percutaneous coronary intervention (PCI) were eventually enrolled in the analysis. Participants were classified into three groups according to baseline FAR levels (T1: FAR < 73.00; T2: 73.00 ≤ FAR < 91.00; T3: FAR ≥ 91.00). The association between FAR and LVSD was assessed by binary logistic regression analysis. A nomogram to predict the risk of LVSD was constructed based on the output indices from multivariate regression analyses.

Results: Patients with LVSD showed significantly higher FAR, monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) than those without. FAR was an independent predictor of left ventricular dysfunction from the multivariate analyses (OR, 1.038; 95%CI, 1.020-1.057; P < 0.001). The area under receiver operating characteristic curve (AUC) of FAR predicting the occurrence of LVSD was 0.735. Meanwhile, FAR was the most powerful predictor than MLR, NLR, and PLR. Nomogram with the AUC reaching 0.906 showed a robust discrimination.

Conclusions: Admission FAR is independently and significantly associated with LVSD in patients with ACS undergoing PCI.

Keywords: Acute coronary syndrome; Fibrinogen-to-albumin ratio; Inflammation; Left ventricular ejection fraction; Left ventricular systolic dysfunction.

MeSH terms

  • Acute Coronary Syndrome* / complications
  • Albumins
  • Cross-Sectional Studies
  • Fibrinogen
  • Humans
  • Percutaneous Coronary Intervention*
  • Retrospective Studies
  • Ventricular Dysfunction, Left*

Substances

  • Albumins
  • Fibrinogen